Utilize Smart Microfluidics to Support Liquid Biopsy Technologies in Detecting Rare Biomarkers for Neurodegeneration in Serum
Magdalena Schimke,
Sales Specialist,
STRATEC Consumables GmbH
Neurodegeneration affects 37 million people annually. Until now, most biomarkers to detect the early onset or progresses of neurodegenerative diseases were retrieved by either imaging technologies or liquor analysis – both eventually very invasive procedures for patients. Smart consumables play a critical role in novel liquid biopsy technologies and market value as they support the finding of novel biomarkers and the possibility to find and characterize rare biomarkers in peripheral body fluids. Thereby, the burden for the patient can be reduced, monitoring tightened and potential treatments initiated earlier, personalized and hence more efficiently applied.
|
|
